Join Bioretec Ltd.'s Upcoming Annual General Meeting Today
Notice of the Annual General Meeting of Bioretec Ltd
The shareholders of Bioretec Ltd are invited to the Annual General Meeting to be held on March 21, 2025, at 11:00 a.m. at the company premises in Tampark. This event promises to be significant for all shareholders and stakeholders.
Annual Meeting Participation
Shareholders can participate in the Annual General Meeting through proxy representation. Proxy representatives must present a dated power of attorney or other reliable proof of their right to represent the shareholder.
To participate in the meeting, shareholders must register by March 11, 2025, at 4:00 p.m. (Finnish time). Details for registration are outlined below in the participation instructions.
Agenda of the Annual General Meeting
The agenda of the Annual General Meeting includes several key points that will shape the company's future direction.
Meeting Opening and Procedures
1. Opening of the meeting
2. Calling the meeting to order
3. Election of persons to scrutinize minutes and supervise vote counting
4. Recording the legality of the meeting
Financials and Reports
5. Presentation of financial statements and the Board of Directors' report for the last financial period
6. Presentation of the auditor's report
7. Approval of the financial statements
Profit Treatment and Board Decisions
8. Treatment of profit or loss
The Board proposes to credit the loss of EUR 4,669,883.08 in the equity, with no dividend distribution planned for the year.
Board of Directors' Matters
9. Discharge from liability of the Board members and CEO for the financial year.
10. Proposal for the remuneration of the Board members, including: Chairperson of the Board: EUR 3,750 per month, Deputy Chairperson: EUR 2,500 per month, and Board members: EUR 2,000 per month.
Board Composition
11. Resolution on the number of Board members: a minimum of three and a maximum of seven members.
The Nomination Board proposes the election of six members.
Board Elections
12. Election of members of the Board of Directors:
Notable nominees include Michael Piccirillo and Sarah van Hellenberg Hubar-Fisher, among others. Their experience and expertise position them well to guide Bioretec's growth.
Future Outlook and Strategy
Bioretec Ltd aims to pursue innovative pathways in biotechnology sector. Continuous improvement and adaptability remain central to our strategic outlook as we navigate market changes and aims. The company's commitment to enhancing shareholder value is paramount and demonstrates through responsible decision-making in financial and operational areas.
Instructions for Participants
1. Shareholders must be registered in the shareholder register by March 11, 2025, to participate in the General Meeting. Registration can be done via email or phone.
2. Nominee-registered shareholders are advised to follow necessary steps for participation as outlined in the respective guidelines.
3. Having a proxy representative is a viable option for shareholders who cannot attend the meeting in person. A dated proxy document or reliable proof will be required.
Frequently Asked Questions
What is the purpose of the Annual General Meeting?
The Annual General Meeting serves to review the company's performance, approve financial statements, and make key decisions regarding the Board of Directors and company policies.
Who is eligible to participate in the meeting?
Only shareholders registered in the shareholder register by the record date can participate. This includes individuals representing the shareholders through proxies.
What documents are required for proxy representation?
A dated proxy document or reliable evidence of the right to represent the shareholder is required for proxy representation at the meeting.
When are the financial statements typically approved?
Financial statements are presented and typically approved during the Annual General Meeting, allowing shareholders to scrutinize and discuss the company's finances.
How can I get more information about the meeting?
More details about the meeting, including various documents, can be found on Bioretec's website.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.